Show
Sort by
-
Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption
-
Structural brain abnormalities in successfully treated HIV infection : associations with disease and cerebrospinal fluid biomarkers
-
- Journal Article
- A1
- open access
High cellular monocyte activation in people living with human immunodeficiency virus on combination antiretroviral therapy and lifestyle-matched controls is associated with greater inflammation in cerebrospinal fluid
-
Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy